INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Jul 21, 2016 |
Director, President Regeneron Laboratori
|
Director, President Regeneron Laboratori | Form 4 | Bona fide gift | 500,000 | -- | 500,000 |
| Jul 21, 2016 |
Director, President Regeneron Laboratori
|
Director, President Regeneron Laboratori | Form 4 | Bona fide gift | 500,000 | -- | 67,976 |
| Dec 17, 2015 |
Director, President and CSO
|
Director, President and CSO | Form 4 | Bona fide gift | 1,921 | -- | 500,000 |
| Dec 17, 2015 |
Director, President and CSO
|
Director, President and CSO | Form 4 | Bona fide gift | 1,921 | -- | 569,897 |
| Nov 16, 2015 |
Director, President Regeneron Laboratori
|
Director, President Regeneron Laboratori | Form 4 | Bona fide gift | 1,612 | -- | 567,976 |
| Nov 02, 2015 |
Director, President and CSO
|
Director, President and CSO | Form 4 | Bona fide gift | 43,348 | -- | 500,000 |
| Nov 02, 2015 |
Director, President and CSO
|
Director, President and CSO | Form 4 | Bona fide gift | 43,348 | -- | 612,936 |
| Dec 16, 2014 |
Director, President Regeneron Laboratori
|
Director, President Regeneron Laboratori | Form 4 | Bona fide gift | 3,264 | -- | 500,000 |
| Dec 16, 2014 |
Director, President Regeneron Laboratori
|
Director, President Regeneron Laboratori | Form 4 | Bona fide gift | 3,264 | -- | 569,588 |
| Nov 14, 2014 |
Director, President Regeneron Laboratori
|
Director, President Regeneron Laboratori | Form 4 | Bona fide gift | 2,313 | -- | 566,324 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.